FDA Authorizes Pfizer COVID-19 Booster Shots For Children Ages 5 To 11

FDA Authorizes Pfizer COVID-19 Booster Shots For Children Ages 5 To 11

The U.S. Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.